TRIM21 and the Function of Antibodies inside Cells

Area of Science:

• Immunology
• Molecular Biology
• Biochemistry

Background:

• Therapeutic antibodies typically target extracellular antigens for cancer and autoimmunity.
• The intracellular functions of antibodies have been historically overlooked.
• Autoantibody research first hinted at intracellular antibody activity.

Purpose of the Study:

• To critically review research on intracellular antibodies.
• To link intracellular antibody activity to the tripartite motif (TRIM) 21 effector mechanism.
• To highlight the potential of therapeutic antibodies in the intracellular space.

Main Methods:

• Literature review of intracellular antibody research.
• Analysis of the tripartite motif (TRIM) 21 pathway.
• Integration of TRIM21's role with intracellular antibody function.

Main Results:

• Antibodies possess functional activity within cells.
• Tripartite motif (TRIM) 21 acts as an intracellular Fc receptor.
• TRIM21 links cytosolic antibody recognition to the ubiquitin proteasome system.

Conclusions:

• Intracellular antibody activity is a significant, previously underestimated, biological process.
• The TRIM21 pathway provides a key mechanism for intracellular antibody effector functions.
• This research opens new avenues for developing intracellularly acting therapeutic antibodies.